Neoadjuvant chemotherapy followed by transoral robotic surgery versus upfront surgery for locoregionally advanced oropharyngeal carcinoma: A propensity score matched analysis.
Claudio SampieriEleonora CioccoloniAndrea CostantinoDahee KimKyuin LeeGiuseppe MeccarielloGiovanni CammarotoClaudio ViciniSe-Heon KimPublished in: Head & neck (2024)
NAC followed by TORS for locoregionally advanced OPSCC demonstrated to achieve non-inferior survival outcomes to upfront surgery, while in the p16-positive population allowed to significantly spare adjuvant therapy.
Keyphrases